Pharmacology of ectonucleotidases: Relevance for the treatment of cardiovascular disorders

European Journal of Pharmacology

Volumn 696, Issue 1-3, 2012, Pages 1-4

  Mathieu, Patrick ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Calcific aortic valve disease; Diabetes; Ectonucleotidase; Pharmacology; Thrombosis

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; BETA,GAMMA DIBROMOMETHYLENE 6 N,N DIETHYLADENOSINE TRIPHOSPHATE; ECTONUCLEOTIDASE; ECTONUCLEOTIDASE INHIBITOR; ECTONUCLEOTIDE PHOSPHODIESTERASE; ECTONUCLEOTIDE PYROPHOSPHATASE; ECTONUCLEOTIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; ENZYME INHIBITOR; G PROTEIN COUPLED RECEPTOR; NUCLEOSIDE; NUCLEOTIDASE; NUCLEOTIDE; NUCLEOTIDE PYROPHOSPHATASE; PHOSPHATE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHODIESTERASE; PROTEIN KINASE B; PURINERGIC P2 RECEPTOR; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC RECEPTOR; PYROPHOSPHATE; THIENOPYRIDINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WARFARIN;

3' UNTRANSLATED REGION; AORTA VALVE DISEASE; ATHEROSCLEROSIS; CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CHRONIC DRUG ADMINISTRATION; COMPLEX FORMATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG ABSORPTION; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME BINDING; ENZYME KINETICS; ENZYME REGULATION; ENZYME SUBSTRATE; ENZYME SYNTHESIS; HUMAN; INSULIN RESISTANCE; INTRACELLULAR SPACE; LIPID STORAGE; MEMBRANE BINDING; MINERALIZATION; NONHUMAN; NUCLEIC ACID SYNTHESIS; NUCLEOTIDE METABOLISM; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULSE WAVE; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE AGGREGATION; THROMBOSIS;

EID: 84869085338     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.09.003     Document Type: Article

References (34)

1. G. Burnstock, and M. Williams P2 purinergic receptors: modulation of cell function and therapeutic potential J. Pharmacol. Exp. Ther. 295 2000 862 869
2. -/- mice J. Vasc. Res. 48 2011 227 235
3. C.N. Chin, Q. Dallas-Yang, F. Liu, T. Ho, K. Ellsworth, P. Fischer, T. Natasha, C. Ireland, P. Lu, C. Li, I.M. Wang, W. Strohl, J.P. Berger, Z. An, B.B. Zhang, and G. Jiang Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity Eur. J. Pharmacol. 606 2009 17 24
4. T. Clair, H.Y. Lee, L.A. Liotta, and M.L. Stracke Autotaxin is an exoenzyme possessing 5-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities J. Biol. Chem. 272 1997 996 1001 (Pubitemid 27034592)
5. N. Cote, H.D. El, A. Pepin, S. Guauque-Olarte, V. Ducharme, P. Bouchard-Cannon, A. Audet, D. Fournier, N. Gaudreault, H. Derbali, M.D. McKee, C. Simard, J.P. Despres, P. Pibarot, Y. Bosse, and P. Mathieu ATP acts as a survival signal and prevents the mineralization of aortic valve J. Mol. Cell Cardiol. 52 2012 1191 1202
6. N. Cote, H.D. El, A. Pepin, C. Bouvet, L.A. Gilbert, A. Audet, D. Fournier, P. Pibarot, P. Moreau, and P. Mathieu Inhibition of ectonucleotidase with ARL67156 prevents the development of calcific aortic valve disease in warfarin-treated rats Eur. J. Pharmacol. 689 2012 139 146
7. D. Delwing, D. Delwing, M.C. Goncalves, J.J. Sarkis, and A.T. Wyse NTPDase and 5'-nucleotidase activities of synaptosomes from hippocampus of rats subjected to hyperargininemia Neurochem. Res. 32 2007 1209 1216 (Pubitemid 46817470)
8. A.N. Drury, and A. Szent-Gyorgyi The physiological activity of adenine compounds with special reference to their action upon the mammalian heart J. Physiol. 68 1929 213 237
9. S. Eliahu, J. Lecka, G. Reiser, M. Haas, F. Bigonnesse, S.A. Levesque, J. Pelletier, J. Sevigny, and B. Fischer Diadenosine 5',5-(boranated) polyphosphonate analogs as selective nucleotide pyrophosphatase/ phosphodiesterase inhibitors J. Med. Chem. 53 2010 8485 8497
10. G.P. Fadini, P. Pauletto, A. Avogaro, and M. Rattazzi The good and the bad in the link between insulin resistance and vascular calcification Atherosclerosis 193 2007 241 244 (Pubitemid 47058124)
11. J.W. Goding Ecto-enzymes: physiology meets pathology J. Leukoc. Biol. 67 2000 285 311
12. J.W. Goding, B. Grobben, and H. Slegers Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/ phosphodiesterase family Biochim. Biophys. Acta 1638 2003 1 19 (Pubitemid 36577366)
13. A. Grupe, J. Alleman, I.D. Goldfine, M. Sadick, and T.A. Stewart Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine J. Biol. Chem. 270 1995 22085 22088
14. J.S. Hulot, J.P. Collet, and G. Montalescot Thienopyridine-associated drug-drug interactions: pharmacologic mechanisms and clinical relevance Curr. Cardiol. Rep. 13 2011 451 458
15. K. Johnson, K. Pritzker, J. Goding, and R. Terkeltaub The nucleoside triphosphate pyrophosphohydrolase isozyme PC-1 directly promotes cartilage calcification through chondrocyte apoptosis and increased calcium precipitation by mineralizing vesicles J. Rheumatol. 28 2001 2681 2691 (Pubitemid 33135656)
16. G. Kauffenstein, A. Drouin, N. Thorin-Trescases, H. Bachelard, B. Robaye, P. D'Orleans-Juste, F. Marceau, E. Thorin, and J. Sevigny NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse Cardiovasc. Res. 85 2010 204 213
17. G. Kauffenstein, C.R. Furstenau, P. D'Orleans-Juste, and J. Sevigny The ecto-nucleotidase NTPDase1 differentially regulates P2Y1 and P2Y2 receptor-dependent vasorelaxation Br. J. Pharmacol. 159 2010 576 585
18. K.M. Khan, N. Fatima, M. Rasheed, S. Jalil, N. Ambreen, S. Perveen, and M.I. Choudhary 1,3,4-Oxadiazole-2(3H)-thione and its analogs: a new class of non-competitive nucleotide pyrophosphatases/phosphodiesterases 1 inhibitors. Bioorg. Med. Chem. 17 2009 7816 7822
19. F. Kukulski, S.A. Levesque, and J. Sevigny Impact of ectoenzymes on p2 and p1 receptor signaling Adv. Pharmacol. 61 2011 263 299
20. S. Kumakura, B.A. Maddux, and C.K. Sung Overexpression of membrane glycoprotein PC-1 can influence insulin action at a post-receptor site J. Cell Biochem. 68 1998 366 377 (Pubitemid 28080128)
21. S.A. Levesque, F. Kukulski, K. Enjyoji, S.C. Robson, and J. Sevigny NTPDase1 governs P2X7-dependent functions in murine macrophages Eur. J. Immunol. 40 2010 1473 1485
22. S.A. Levesque, E.G. Lavoie, J. Lecka, F. Bigonnesse, and J. Sevigny Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases Br. J. Pharmacol. 152 2007 141 150 (Pubitemid 47339903)
23. B.A. Maddux, P. Sbraccia, S. Kumakura, S. Sasson, J. Youngren, A. Fisher, S. Spencer, A. Grupe, W. Henzel, and T.A. Stewart Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus Nature 373 1995 448 451
24. Y. Nitschke, G. Weissen-Plenz, R. Terkeltaub, and F. Rutsch Npp1 promotes atherosclerosis in ApoE knockout mice J. Cell Mol. Med. 15 2011 2273 2283
25. R.A. North Molecular physiology of P2X receptors Physiol. Rev. 82 2002 1013 1067
26. I.R. Orriss, G. Burnstock, and T.R. Arnett Purinergic signalling and bone remodelling Curr. Opin. Pharmacol. 10 2010 322 330
27. E. Robin, J. Sabourin, R. Benoit, S. Pedretti, and E. Raddatz Adenosine A1 receptor activation is arrhythmogenic in the developing heart through NADPH oxidase/ERK- and PLC/PKC-dependent mechanisms J. Mol. Cell Cardiol. 51 2011 945 954
28. S.C. Robson, J. Sevigny, and H. Zimmermann The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance Purinergic Signal 2 2006 409 430
29. M.R. Schetinger, V.M. Morsch, C.D. Bonan, and A.T. Wyse NTPDase and 5-nucleotidase activities in physiological and disease conditions: new perspectives for human health Biofactors 31 2007 77 98
30. J. Sevigny, C. Sundberg, N. Braun, O. Guckelberger, E. Csizmadia, I. Qawi, M. Imai, H. Zimmermann, and S.C. Robson Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation Blood 99 2002 2801 2809 (Pubitemid 34525368)
31. M.Y. Speer, and C.M. Giachelli Regulation of cardiovascular calcification Cardiovasc. Pathol. 13 2004 63 70 (Pubitemid 38366423)
32. C. Stefan, S. Jansen, and M. Bollen NPP-type ectophosphodiesterases: unity in diversity Trends Biochem. Sci. 30 2005 542 550 (Pubitemid 41356492)
33. D.A. Towler Inorganic pyrophosphate: a paracrine regulator of vascular calcification and smooth muscle phenotype Arterioscler.Thromb.Vasc. Biol. 25 2005 651 654 (Pubitemid 40463849)
34. G.G. Yegutkin Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade Biochim. Biophys. Acta 1783 2008 673 694